Le Lézard
Classified in: Health
Subject: SCZ

GlucoseZonetm Launches First Diabetes Exercise Program for Seniors


NEW HAVEN, Conn., June 18, 2019 /PRNewswire-PRWeb/ -- GlucoseZone, the first-ever clinically validated digital exercise therapeutic for people living with diabetes, today announced its latest addition to the company's expanding fitness program offerings, Vitality.
Vitality is an easy to follow, fun, and exciting workout series for seniors living with diabetes. In this series, Curtis Adams, host of senior exercise TV show "A New Way 2 Move", provides clear instruction of the movements needed to help you manage your diabetes, stay active, and get energized. Each workout includes a modified version so that seniors of all mobility levels can get involved.

"I am honored to work with GlucoseZone to create Vitality and help seniors fight back against their diabetes," said Adams. "My passion to create fun exercises that motivate seniors has been life changing and I'm thrilled to be helping seniors all over the world combat diabetes."

"We are excited to be working with Curtis on this phenomenal new program which will tremendously help seniors living with diabetes and prediabetes," said Charlie O'Connell, Founder of GlucoseZone. "It's long been our goal to help those suffering from the disease. We saw a gap in senior diabetes exercise and therefore decided to create Vitality to help manage their diabetes, lose weight, and improve their overall health."

Diabetes and prediabetes impact the lives and health of more than 114 million Americans. While exercise has long been recognized as a key component in the prevention and management of diabetes, GlucoseZone provides a new resource to address the unique challenges of exercise with diabetes.

About GlucoseZone by Fitscript, LLC
Created in 2012, Fitscript LLC was founded to help people living with diabetes safely and effectively meet the exercise requirement for managing their diabetes. Fitscript's patented, proprietary GlucoseZone program, is the first-ever digital exercise therapeutic for people living with diabetes that offers people tailored exercise programs and workouts specific to their diabetes type, blood sugar levels and medications prescribed to achieve better results and improve their overall health. The GlucoseZone program offers live and on-demand exercise routines, digital coaching, diabetes discussions and much more. GlucoseZone brings you a convenient and personalized experience on your phone, tablet, or computer and is currently available on iOS and Android. To learn more about GlucoseZone, please visit http://www.glucosezone.com. Connect with GlucoseZone's social media channels: http://www.youtube.com/GlucoseZone and http://www.facebook.com/glucosezone.

Media Contact for Fitscript/GlucoseZone:
JMediaHouse
Jason Geller
jason(at)jmediahouse(dot)com
212-920-0398

 

SOURCE GlucoseZone


These press releases may also interest you

at 07:35
Agenus Inc. ("Agenus") , a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Agenus executives...

at 07:34
Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An," the "Company" or the "Group," HKEX: 2318; SSE: 601318) today announced its first quarter financial results for the three months ended March 31, 2024....

at 07:31
Tharimmune, Inc. ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation & immunology, announced today an option agreement for an...

at 07:30
KFSH&RC participates as a strategic partner in the Saudi American Healthcare Forum, which will take place on April 25th under the patronage of the Ministry of Health in Riyadh. This forum aims to discuss the primary healthcare challenges facing the...

at 07:30
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on...

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....



News published on and distributed by: